Nature, in its intricate design, has bestowed upon us a hidden arsenal in the form of antimicrobial peptides (AMPs) – small, naturally occurring molecules that play a pivotal role in the innate immune response of various organisms. These peptides, a product of millions of years of evolutionary refinement, possess remarkable antimicrobial properties, challenging the traditional paradigms of antibiotic development. AMPs act as nature's guardians, defending against invading pathogens with a multifaceted approach. They disrupt microbial cell membranes, target intracellular components, and even modulate immune responses. Their versatility and ability to combat a broad spectrum of microorganisms make them promising candidates for novel antimicrobial therapies. Scientists are unraveling the secrets of AMPs, seeking inspiration for the development of synthetic counterparts. By understanding the structural motifs and mechanisms of action employed by these peptides, researchers aim to design antimicrobial agents that mimic nature's elegance. This approach holds the potential to overcome the challenges posed by antibiotic resistance, as AMPs present a unique strategy that bacteria are less likely to develop resistance against.
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : Changing population immunity to COVID-19 in the context of infection, vaccination, and emerging SARS-CoV-2 variants
Ranjan Ramasamy, ID-FISH Technology, United States
Title : From bench to preclinical evaluation: LL-37-derived peptides for combating orthopedic infections
Vincenzo Pennone, IRCCS Galeazzi Sant’Ambrogio Hospital, Italy
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain
Title : Personalized and precision medicine (PPM) as a unique healthcare model to se-cure the human healthcare, wellness and biosafety through the view of public health, network driven healthcare services and lifestyle management
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation